The future of oncology is being built through collaboration​New Phase CEO Ofer Shalev, together with our Principal Scientist and Director of Biology, Dr. Sarah Kraus, participated in the Mayo Clinic Research Innovation Summit, highlighting our breakthrough nanoparticle selective hyperthermia technology. Following our system installation at Mayo Clinic for our ongoing U.S. clinical trials, we’re thrilled to work alongside world-class institutions to bring deep-tissue, non-invasive cancer solutions to patients who need them most.